Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-15-013970
Filing Date
2015-10-09
Accepted
2015-10-09 17:04:46
Documents
1
Period of Report
2015-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 9409
  Complete submission text file 0001179110-15-013970.txt   10757
Mailing Address C/O ACCELERON PHARMA INC. 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
MCLAUGHLIN KEVIN F (Reporting) CIK: 0001214938 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36065 | Film No.: 151153863

Mailing Address 128 SYDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SYDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Issuer) CIK: 0001280600 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)